Environmental stimuli previously paired with drug taking appear to play a critical role in nicotine dependence. Converging anatomical, pharmacological, and behavioral evidence implicates dopamine D 3 receptors (D 3 Rs) in the mechanisms underlying stimulus-controlled drug-seeking behavior. This study assessed the effects of BP 897, a D 3 R partial agonist and ST 198, a D 3 R antagonist, on nicotine-induced conditioned place preferences (CPPs), used as a measure of drug-seeking behavior, on food-maintained responding and on discrimination performance under a two-lever-choice nicotine discrimination procedure. BP 897 and ST 198 both blocked the expression of nicotine-induced CPP at doses selective for D 3 R. They had no effect on locomotor activity in the CPP apparatus and no significant effect on nicotine discrimination performance or food-maintained responding under the discrimination procedure. Involvement of antidepressant actions in the effects of BP 897 and ST 198 on CPP is unlikely, since we found no effect of D 3 R blockade with BP 897 or genetic depletion of D 3 Rs in a forced swimming test, used as a behavioral test for antidepressant activity. This suggests that D 3 R ligands reduce the motivational effects of nicotine by a mechanism distinct from those of nicotine replacement therapy and bupropion, the two currently used aids for smoking cessation in humans. These findings support the use of D 3 R ligands as aids for smoking cessation and indicate that their effects would be selective for those rewarding or reinforcing effects of nicotine that contribute to the maintenance of tobacco-smoking behavior, without affecting subjective responses to nicotine or producing any antidepressant-like effects.
INTRODUCTION
The dopaminergic mesolimbic system, which originates in the ventral tegmental area, and projects, notably, to the nucleus accumbens, is critically involved in the reinforcing effects of drugs of abuse. The ability to increase levels of dopamine in the nucleus accumbens is a common feature of all addictive drugs, including nicotine (Imperato et al, 1986; Pidoplichko et al, 1997) , that seems implicated in their reinforcing effects (Wise and Rompre, 1989) . Maintenance of and relapse to drug-seeking and drug-taking behavior can be markedly facilitated by environmental stimuli that acquire motivational salience through repeated associations with a self-administered drug (Schuster and Woods, 1968; Goldberg, 1973; Goldberg and Gardner, 1981; Stewart et al, 1984; Robinson and Berridge, 1993; Childress et al, 1999) , and presentation of stimuli previously associated with administration of cocaine or amphetamine can elevate dopamine levels in the nucleus accumbens (Di Ciano et al, 1998a, b; Ito et al, 2000) , a factor that may trigger drug-seeking behavior (Phillips et al, 2003) . These factors may be particularly important in nicotine dependence (Caggiula et al, 2001) , since environmental stimuli associated with nicotine administration play a critical role in sustaining intravenous nicotine self-administration behavior by animals (Caggiula et al, 2002a, b) .
There is a growing body of evidence indicating that reactivity to drug-associated stimuli is controlled by D 3 receptors (D 3 Rs) , 2002 , 2003a . In marked contrast to D 1 and D 2 receptors, the D 3 R has a restricted pattern of expression in the rat brain, with selective expression in the nucleus accumbens (Bouthenet et al, 1991; Diaz et al, 1995 Diaz et al, , 2000 , a brain area strongly implicated in reinforcing effects of drugs of abuse (Koob, 1992) . The density of D 3 Rs is elevated in long-term cocaine abusers (Staley and Mash, 1996; Segal et al, 1997) and in cocaine-treated animals (Le Foll et al, 2002) . A selective increase in D 3 R binding and D 3 R mRNA has also been found in the shell of the nucleus accumbens of nicotinetreated rats, without any significant changes in the expression of D 1 and D 2 receptors (Le Foll et al, 2003a, b) .
Analysis of the role of D 3 Rs in drug dependence processes has recently been facilitated by the availability of highly selective ligands. The D 3 R partial agonist, BP 897, displays a 70-fold selectivity for D 3 over D 2 receptors and is able to reduce cue-induced cocaine-seeking behavior (Pilla et al, 1999) and conditioned hyperactivity produced by stimuli previously associated with cocaine administration (Le Foll et al, 2002) . Similar effects (Le Foll et al, 2002; Di Ciano et al, 2003) have been found with the D 3 R antagonist, SB-277011-A (trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolininecarboxamide), which has a high affinity for the D 3 R and a 100-fold selectivity for D 3 over D 2 receptors (Reavill et al, 2000) . These D 3 ligands also block cocaine- (Vorel et al, 2002; Duarte et al, 2003) and opiates-induced (Ashby et al, 2003; Francès et al, 2004a) conditioned place preferences (CPPs). Such findings suggest that D 3 R partial agonists and antagonists may be particularly useful for decreasing the influence of conditionedenvironmental stimuli on drug-seeking behavior and, thus, reducing the tendency for relapse .
Since environmental stimuli repeatedly associated with nicotine administration appear to be particularly important in nicotine dependence (Caggiula et al, 2001 (Caggiula et al, , 2002a , D 3 R ligands may be clinically useful tools for reducing relapse to smoking behavior in human tobacco users (Le Foll et al, 2003a) . In one recent study evaluating the effects of D 3 R blockade on nicotine self-administration by rats, however, nicotine-associated stimuli failed to re-initiate extinguished nicotine-seeking behavior and D 3 R blockade by SB-277011-A mainly decreased the re-initiation of extinguished nicotine-seeking behavior that was produced by a presession priming injection of nicotine (Andreoli et al, 2003) . This would suggest that D 3 R blockade primarily alters the reinforcing effects of nicotine and interoceptive discriminative-stimulus effects of nicotine that trigger re-initiation of drug-seeking behavior. Also, nicotine replacement and bupropion are the two medications most frequently used to treat nicotine dependence in humans and bupropion has clear nicotine-like discriminative-stimulus effects in rats (Wiley et al, 2002; Young and Glennon, 2002) .
To further assess the effects of D 3 R blockade on the control of nicotine-seeking behavior by conditioned-environmental stimuli, we used a CPP procedure, an animal model involving the direct control of nicotine-motivated behavior by associated environmental stimuli (Le Foll and Goldberg, 2004a, b) . To assess the effects of D 3 R blockade on nicotine's discriminative-stimulus and psychomotor effects, we used a classical two-lever choice drug-discrimination procedure (Colpaert, 1999) . Two D 3 R ligands, BP 897, a selective D 3 R partial agonist and ST 198, 2, 3, -butyl)-3-phenylacrylamide), a recently described D 3 R antagonist, were evaluated with these two procedures at doses selective for the D 3 R. ST 198 presents a 65-fold selectivity for the D 3 over the D 2 receptor (Bezard et al, 2003; Mach et al, 2004) : inhibition constants (K i ) are 12 and 780 nM for inhibiting binding to D 3 and D 2 receptors, respectively (Bezard et al, 2003) . ST 198 has a lower affinity for human D 1 (K i E25 mM), D 4.4 (K i E5 mM), and D 5 (K i E12 mM) receptors, as well as for a variety of nondopaminergic receptors (Bezard et al, 2003) . BP 897 and ST 198 were tested for their effects on the expression of preferences that had developed for distinctive compartments repeatedly associated with nicotine administration under the CPP procedure, and for their effects on food-maintained responding and discrimination performance under the nicotine discrimination procedure.
Finally, since two antidepressant drugs (bupropion and nortriptyline) are effective aids for smoking cessation in humans (Fiore et al, 2000) , we considered the possibility that any effectiveness of D 3 R ligands in the treatment of nicotine dependence or the reduction of nicotine-induced CPP might be related to antidepressant effects. This hypothesis is strengthened by the putative role of dopamine and D 3 Rs in the regulation of mood (Maj et al, 1997; Willner, 1997; Lammers et al, 2000) . Bupropion and nortriptyline, as well as other antidepressants such as imipramine, all have positive effects on performance in the forced swimming test (Porsolt et al, 1977; Steru et al, 1985; Zocchi et al, 2003) , but D 3 R ligands have not been studied with this procedure. To address the issue of potential antidepressant effects of D 3 R ligands, we compared the effects of BP 897 and imipramine in the forced swimming test. In addition, D 3 R-deficient mice and their wild-type littermates were used to further assess the effect of D 3 R blockade by genetic deletion alone and in combination with imipramine treatment on performance in the forced swimming test.
MATERIALS AND METHODS
Rats used in this study were maintained in facilities fully accredited by the American Association for the Accreditation of Laboratory Animal Care (AAALAC), and all experimentation was conducted in accordance with the guidelines of the Institutional Care and Use Committee of the Intramural Research Program, National Institute on Drug Abuse, NIH, and the Guide for Care and Use of Laboratory Animals. All experimental procedures involving mice were in strict accordance with the guidelines of the French Ministry of Agriculture on the use and care of laboratory animals.
Drugs
Nicotine ((À)-nicotine hydrogen tartrate) and imipramine (imipramine hydrochloride) were purchased from Sigma Chemical Company (St Louis, MO, USA) and diluted in saline. pH of nicotine was adjusted to 7.0 with dilute NaOH. Nicotine was administered in a volume of 1.0 ml/kg subcutaneously (s.c.), immediately before the session for the CPP experiment and 10 min before the session for the nicotine discrimination experiments. BP 897 (gift from Bioprojet laboratory, Paris, France) and ST 198 (synthesized at Johann Wolfgang Goethe University, Frankfurt, Germany) were dissolved in water and administered 30 min before the sessions. Imipramine was administered intraperitoneally, 30 min before the test. The pH of the ST 198 solution was adjusted to pH 6 with NaOH 0.1 N. ST 198 was administered orally by Kendall s feeding tubes. All doses of the drugs were expressed as mg free base per kg body weight.
Experiment 1: Nicotine-Induced CPPs Subjects. Male Sprague-Dawley rats (n ¼ 247) were obtained from Charles River (Wilmington, MA). They were experimentally naive at the start of the study, initially weighed 230-260 g and were housed in groups of two per cage. Water and lab chow were available at all times in the home cage. Experimental procedures were conducted during the light phase of a 12-h/12-h light/dark cycle (lights on at 0700 h). The rats were allowed to acclimate to the animal colony for at least 3 weeks before training and were repeatedly handled during this period. All rats were housed in a temperature-and humidity-controlled room. A total of 37 rats displaying a high initial bias in the apparatus (ie more than 600 s spent in one side of the apparatus over a 900 s period of time) were eliminated from the study. Therefore, data from 210 rats were analyzed (103 rats in the saline groups and 107 rats in nicotine groups).
Apparatus. Eight identical locomotor activity monitors (MED Associates, St Albans, VT) were enclosed in four sound-attenuation chambers (BRS/LVE, Laurel, MD). A standard two-compartment place preference insert (42 Â 42 cm 2 , Med Associates) was situated inside each locomotor activity monitor. The two sides of the apparatus were differentiated by their floor type (mesh vs bar) and a small light was added on the wall of the sound-attenuation chambers on the side of the mesh floor, to increase the difference between the two sides. Each monitor consisted of a 16 Â 16 infrared photocell array separated by 2.5 cm. These detectors were interfaced to a computer that tabulated the time spent per side and distance traveled. Thus, the time spent in one compartment could be deducted from the time spent in the other compartment (sum of both equaled 900 s). This CPP apparatus produces only minimal bias: the rats tend to prefer the grid-mesh floor over the bar side in our apparatus (53.2 vs 46.8% of the total time of the pre-test session) (Le Foll and Goldberg, 2004a) .
Procedure. Each CPP experiment had three phases: one pretest, six conditioning sessions, and one post-test session. These sessions were conducted over 5 subsequent days (two sessions per day for conditioning sessions).
Pre-test: A 900-s pre-test was given to determine initial preference for the floor and illumination stimuli using a procedure identical to that used for the post-conditioning preference test. All rats were weighed just before placement in the apparatus. Animal placement (ie mesh vs bar side of the chamber) was counterbalanced within each subgroup. During the pre-test, rats could move freely from side to side in the place preference apparatus.
Conditioning: We used a 'biased' stimulus assignment procedure, that is, the compartment paired with nicotine was the initially nonpreferred side of the apparatus, as measured during the pre-test. In the morning, all rats received an s.c. injection of saline before being placed for 20 min in one compartment. After 4 h, rats received an injection of either 0.1 mg/kg nicotine (nicotine conditioning) or saline (saline conditioning) before being placed for 20 min in the other compartment. Recently, we have demonstrated that nicotine is able to induce CPP over a large range of doses (Le Foll and Goldberg, 2004a ), but we found a maximal effect at 0.1 mg/kg and this was within the range of doses most frequently found effective in inducing CPP in rats by others (Le Foll and Goldberg, 2004a) . Since, nicotine's ability to induce place preference is highly dependent on the stimulus assignment procedure used (Acquas et al, 1989; Calcagnetti and Schechter, 1994; Le Foll and Goldberg, 2004a) , we chose a bias procedure in which the animals received nicotine administrations in the initially nonpreferred compartment of the CPP apparatus, as assessed by a preconditioning test. This bias procedure appears more suitable than unbiased procedures for studying nicotine-induced CPP, since nicotine administrations in the initially preferred compartment of the CPP apparatus were not able to induce CPP in our previous study (Le Foll and Goldberg, 2004a) .
Place preference test: The CPP test was given the day after the last conditioning trial. The conditions of this test were identical to those during the pre-test session, that is, the rats could move freely from side to side in the place preference chamber. Rats were treated acutely with either saline, BP 897 (0.1, 0.3, and 1 mg/kg, n ¼ 14-16) or ST 198 (3, 30, and 100 mg/kg, n ¼ 12-14), 30 min before the place preference test.
Data analysis. The outcome of the CPP experiment was determined by analyzing the raw time scores in the less preferred side of apparatus. All data were subjected to a repeated measure of analysis of variance (ANOVA, pre-test and post-test) with the alpha level set at 0.05. Post hoc comparisons were performed with LSD post hoc test. We first compared the time spent in the initially less preferred side of the apparatus by rats of various groups during the pre-test. Nicotine place preferences were determined by comparing the time spent in the initially less preferred side of the apparatus (drug-paired side) by the various groups to the time spent by the saline control group. Distance traveled during the test session was also analyzed.
Experiment 2: Nicotine Discrimination
Subjects. Male Sprague-Dawley rats (Charles River, Wilmington, MA) experimentally naive at the start of the study and initially weighing 290-350 g were housed individually. The rats were allowed 7 days of free feeding after being delivered to the animal facility. Before the start of the study, rats were diet restricted (3 NIH07 biscuits/day) for 10 days and the diet restriction was maintained throughout the study to maintain the animal weight at 85% of their ad lib weight at the beginning of the study. Enrichments (fresh fruits and vegetables) were provided on Saturdays. Water was available ad libitum. All rats were housed in a temperature-and humidity-controlled room and were maintained on a 12 h light/dark cycleFthe lights were on from 0700 to 1900 h. Experiments were conducted during the light phase.
Apparatus. A total of 12 standard operant-conditioning chambers (Coulbourn Instruments, Lehigh Valley, PA) were used. Each chamber contained a white house light and two levers, separated by a recessed tray into which a pellet dispenser could deliver 45 mg food pellets (F0021, Bioserv, Frenchtown, NJ). Each press of a lever with a force of 0.4 N through 1 mm was recorded as a response and was accompanied by an audible click. The operant-conditioning chambers were controlled by microcomputers using the MED Associates MED-PC software package (MED Associates Inc., East Fairfield, VT).
Drug-discrimination procedure. Rats were trained as described previously (Yasar and Bergman, 1994; Le Foll and Goldberg, 2004b ) under a discrete-trial schedule of food-pellet delivery to respond on one lever after an injection of a training dose of 0.4 mg/kg nicotine, and on the other lever after an injection of 1 ml/kg of saline vehicle (n ¼ 24). Injections of nicotine or saline were given subcutaneously 10 min before the start of the session. At the start of the session, a white house light was turned on and in its presence the rats were required to make 10 consecutive responses (fixed ratio 10 schedule of food delivery) on the lever appropriate to the pre-session treatment. The completion of 10 consecutive responses on the correct lever produced delivery of a 45 mg food pellet and initiated a 45-s time-out, during which lever-press responses had no programmed consequences and the chamber was dark. Responses on the incorrect lever had no programmed consequences other than to reset the fixedratio requirement on the correct lever. After each time-out, the white house light was again turned on and the next trial began. Each session ended after completion of 20 fixed-ratio trials or after 30 min elapsed, whichever occurred first. Discrimination-training sessions were conducted 5 days per week under a double alternation schedule (ie DDSSDDSS, etc, D ¼ drug; S ¼ saline). Training continued until there were eight consecutive sessions, during which rats completed at least 90% of their responses during the session on the correct lever and no more than four responses occurred on the incorrect lever during the first trial. Test sessions with other doses and other drugs were then initiated.
During the test sessions, a range of doses of BP 897 (0.1, 0.3, 1, 3, and 10 mg/kg) and ST 198 (3, 10, 30 , and 100 mg/ kg) were substituted for the training dose of nicotine and were given in combination with 0.4 mg/kg nicotine. These D 3 ligands were also administered together with various doses of nicotine to assess possible shifts in the doseresponse curve for nicotine discrimination (0.3 and 1 mg/kg of BP897 and 30 and 100 mg/kg of ST 198 were tested): we used a within-subjects design: the same rats received the various treatments regimen during various test sessions. Test sessions were identical to training sessions, with the exception that both levers were active and 10 consecutive responses on either one of the two levers resulted in delivery of a food pellet. Switching responding from one lever to the other lever reset the ratio requirement. In a test phase, a single alternation schedule was introduced and test sessions were usually conducted on Tuesdays and Fridays. Thus, a 2-week sequence starting on Monday was: DTSDTSTDST (T ¼ test). In this way, test sessions occurred with equal probability after saline and drug sessions. Test sessions were conducted only if the criterion of 90% accuracy and not more than four incorrect responses during the first trial was maintained in the two preceding training sessions.
Data analysis. Two independent measures of behavior were collected in the nicotine-discrimination study: a measure of discrimination performance expressed as the percentage of nicotine-associated responses and a measure of motor performance expressed as response rate. The percentage of nicotine-associated responses during each session (training or test) reflected the percentage of the number of responses emitted on the nicotine-associated lever relative to the total number of responses emitted on both levers during a session. The percentage of nicotine-associated responses was individually calculated for each rat and then expressed as a group mean (7SEM). Nicotine-associated lever selection data were excluded from analysis if a rat emitted fewer than 10 responses during the test session or if the response rate was inferior to 0.5 responses/s. No generalization to the nicotine cue was defined as the percentage of responses on the nicotine-associated lever was 20% or lower. Response rate (responses/s) during each session was calculated by dividing the total number of responses emitted on both levers during a session by the total session length. Response rates were individually calculated for each rat and then expressed as a group mean (7SEM).
ANOVA was used to analyze experimental data from the nicotine-discrimination study. Post hoc analysis was performed using Dunnett's test following detection of a significant main effect (ie a significant effect of drug's dose for within group comparisons) by one-way ANOVA. Statistical analyses were performed on raw (rates of responding) or transformed (percentages of nicotineassociated lever selections) data. ED 50 values and 95% confidence intervals (CIs) for nicotine dose-response curves after different pretreatments were calculated by linear regression using four or five points on the ascending portions of the dose-response curves. Data were considered statistically significant at Po0.05. Two ED 50 values were considered statistically different if their 95% confidence limits did not overlap.
Experiment 3: Assessment of Antidepressant Actions with a Forced Swimming Test
Subjects. Experiments were conducted with either male Swiss mice (n ¼ 9-11) or with D 3 R-deficient mice and their wild-type littermate (n ¼ 12), obtained from breeding and mating C57Bl6 Â 129sv hybrid heterozygous mice bearing a mutation invalidating the D 3 R gene, originally obtained from S. Fuchs (Weizmann Institute, Rehovot, Israel) (Accili et al, 1996) . DNA was prepared from a piece of the tail (3-5 mm), using the DNAeasy tissue kit (Qiagen France, Courtaboeuf, France), and amplified with the mixture of primers GCA GTG GTC ATG CCA GTT CAC TAT CAG and CCT GTT GTG TTG AAA CCA AAG AGG AGA GG, amplifying exon 3 of the wild-type D 3 R, and TGG ATG TGG AAT GTG TGC GAG and GAA ACC AAA GAG GAG AGG Measurement of forced swimming time. All mice were grouped four per cage for 1 week prior to the experiment, on a 12 h/12 h light/dark cycle (lights on at 0700 h), with food and water available ad libitum. Home cages measured were 25 cm wide Â 15 cm large Â 13 cm high and the floor was covered by sawdust. Mice were brought to experimental rooms 2 h before the experiments. The forced swimming time was used to measure immobility and escape time in mice (for details, see Porsolt et al, 1977) . The apparatus consisted of two glass cylinders (height: 25 cm; diameter: 10 cm), each containing 10 cm of water at 23À251C. Two mice were placed into the cylinders for 6 min and tested at the same time. Immobility time was measured during the last 4 min of the 6-min testing period. A mouse was judged to be immobile when it floated in an upright position and made only small movements to keep its head above water. Results were converted to escape time (reflecting total time minus immobility time).
Statistical analysis. Values reported are means7SEM. Differences between groups of Swiss mice treated with saline, imipramine (32 mg/kg i.p.) and BP 897 (1 and 2 mg/ kg i.p.) were analyzed by one-way ANOVA, followed by the Dunnett's multiple comparison post hoc test. Differences between D 3 R-deficient mice and their wild-type littermate were analyzed by two-way ANOVA, followed by LSD post hoc test.
RESULTS

Experiment 1: Nicotine CPPs
Times spent in the initially less preferred side of the apparatus during the pre-conditioning test by the rats from the different groups are shown in Figure 1 (open bars). There were no basal differences between groups (all P40.3). After conditioning with a dose of 0.1 mg/kg nicotine, and in agreement with our previous studies (Le Foll and Goldberg, 2004a, b) , rats displayed nicotine-induced CPP: repeated measures of ANOVA indicated a significant effect of time (F(1, 196 ) ¼ 18.6, Po0.0001), no significant effect of nicotine treatment (F(1, 196) ¼ 0.5, P ¼ 0.06), but a significant time Â nicotine treatment interaction (F(1, 196) ¼ 5.1, P ¼ 0.03). Post hoc analysis indicated that there were significant nicotine-induced CPPs in rats receiving either saline (Po0.0001), BP 897 at the 0.1 mg/kg dose (P ¼ 0.006), and ST 198 at the 3 mg/kg (P ¼ 0.01) and 30 mg/kg (P ¼ 0.007) doses, as compared to saline control animals. As stated in Materials and methods, nicotine-induced CPP is defined by comparison with the group of rats receiving saline in both compartments during conditioning sessions and treated with saline the test day. In contrast, there were no significant nicotine-induced CPPs in rats receiving BP 897 at the higher 0.3 (P ¼ 0.17) and 1 mg/kg (P ¼ 0.053) doses or ST 198 at the 100 mg/kg dose (P ¼ 0.2) (left part of Figure 1 ). These compounds were also given to control, saline-pretreated animals (right part of the Figure 1) , and there were no significant effects, except an increase in the time spent in the nonpreferred side of the apparatus at the 1 mg/kg dose of BP 897 (P ¼ 0.005).
Locomotor activities displayed by the rats during test sessions are shown in Figure 2 . Neither BP 897 nor ST 198 administration altered locomotor activity of the rats in these experiments. Repeated measures of ANOVA indicate no significant effect of nicotine conditioning (F(1, 179) ¼ 0.01, P ¼ 0.91), no significant effect of BP 897 or ST 198 administration (F(6, 179) ¼ 0.86, P ¼ 0.52), and no significant conditioning Â treatment interaction (F(6, 179) ¼ 0.53, P ¼ 0.78).
Experiment 2: Nicotine Discrimination
Establishment of the nicotine discrimination baseline. To reach the final level of accuracy (eight consecutive sessions with at least 90% of the responses on the correct lever and no more than four incorrect responses during the first trial) Rates of responding during training sessions were stable across sessions during the whole study and were slightly higher after nicotine than after saline pretreatment, as was observed in previous studies using the same 0.4 mg/kg training dose of nicotine (Shoaib et al, 1997; Gasior et al, 2002) . When doses of 0.01-0.6 mg/kg nicotine were substituted for the 0.4 mg/kg training dose, there was a dose-dependent reduction in responding on the drug lever as dose decreased with responding almost exclusively on the drug lever at 0.1-0.6 mg/kg and responding almost exclusively on the saline lever at the lower dose of 0.01 mg/kg nicotine (one-way ANOVA: F(5,138) ¼ 92.9, Po0.0001, Figure 3 , left upper panel). The nicotine dose-response curve remained stable throughout the study.
Generalization tests with BP 897 and ST 198. . Post hoc analysis indicated that BP 897 had no effect on responding at doses between 0.1 and 3 mg/kg (all P40.53), but significantly decreased responding at a dose of 10 mg/kg (Figure 3 , P ¼ 0.002), a 30-fold higher dose than that which blocked the expression of nicotine-induced CPP (0.3 mg/kg, Figure 1 ). ST 198 had no effect on the rates of responding at doses up to 100 mg/ kg, the dose which blocked the expression of nicotineinduced CPP (one-way ANOVA F(4,42) ¼ 1.51, P ¼ 0.21). Due to the limited availability of ST 198, higher doses were not tested. These results indicate that the two D 3 ligands do not produce nicotine-like effects and do not disrupt behavior at doses selective for the D 3 R.
Effects of BP 897 and ST 198 on the discriminativestimulus effects of the training dose of nicotine. 198, at doses selective for the D 3 R, did not block or significantly reduce the discriminative-stimulus effects of the training dose of nicotine (all P40.2). BP 897 in combination with the training dose of nicotine also had no significant effect on response rates, compared to nicotine alone (one-way ANOVA F(4,25) ¼ 0.6, P ¼ 0.7), although there was a trend for increased response rates at doses of 0.1-1 mg/kg (Figure 3) . When ST 198 was given in combination with the training dose of nicotine, there was a significant change in response rates (one-way ANOVA F(4,25) ¼ 3.05, P ¼ 0.04). Post hoc analysis indicated that the low 3 mg/kg ST 198 significantly increased response rates compared to nicotine alone (P ¼ 0.04); a similar trend has been noticed for ST 198 at the dose of 10 and 30 mg/kg (see Figure 3 , P ¼ 0.08 for both), but not for the dose of 100 mg/ kg (P ¼ 0.6). These results indicate that the two D 3 ligands do not block the discriminative-stimulus effects of 0.4 mg/ kg nicotine.
Effects of D 3 R selective doses of BP 897 and ST 198 on the dose-response curve for nicotine discrimination. Figure 4 shows the effects of selected doses of BP 897 and ST 198 on the dose-response curve for nicotine discrimination. ED 50 values for drug-lever selection with 95% CIs are presented in Table 1 . Neither BP 897 nor ST 198, at the highest doses selective for the D 3 R, produced a significant shift of the dose-response curve for nicotine discrimination (Figure 4 ). This lack of effect is also indicated by overlapping 95% CIs of ED 50 values (Table 1) given acutely 30 min before the session did not modify the discrimination of nicotine (no shift of the curve); nicotine dose-response curves after pretreatment with BP 897 (left panels) and ST 198 (right panels). Data are means (7SEM) from five to six nicotine-trained rats. The percentage of responses on the lever associated with nicotine administration is shown as a function of dose (mg/kg, log scale) (upper panels). Response rates are expressed as responses per second (bottom panels). ED 50 values with 95% CIs for these dose-response curves are given in Table 1 . Overlapping 95% CI compared with the dose-response curves of nicotine alone.
D 3 R and nicotine effects B Le Foll et al BP 897 at doses of 0.3 and 1 mg/kg in combination with various doses of nicotine significantly increased response rates, compared to nicotine alone. For experiments with BP 897 at the dose of 0.3 mg/kg, two-way ANOVA revealed a significant effect of BP 897 (F(1,50) ¼ 5.33, P ¼ 0.03), no significant effect of nicotine dose (F(4,50) ¼ 1.22, P ¼ 0.31), and no significant interaction between BP 897 and the dose of nicotine (F(4,50) ¼ 1.21, P ¼ 0.32). For experiments with BP 897 at the dose of 1 mg/kg, two-way ANOVA revealed a significant effect of BP 897 (F(1,50) ¼ 5.23, P ¼ 0.03), no significant effect of nicotine dose (F(4,50) ¼ 0.53, P ¼ 0.71), and no significant interaction between BP 897 and the dose of nicotine (F(4,50) ¼ 0.77, P ¼ 0.55).
ST 198 at doses of 30 and 100 mg/kg in combination with various doses of nicotine significantly also increased response rates, compared to nicotine alone. For experiments with ST 198 at the dose of 30 mg/kg, two-way ANOVA revealed a significant effect of ST 198 (F(1,60) ¼ 4.62, P ¼ 0.04), no significant effect of nicotine dose (F(5,60) ¼ 1.16, P ¼ 0.34), and no significant interaction between ST 198 and the dose of nicotine (F(5,60) ¼ 1.63, P ¼ 0.17). For experiments with ST 198 at the dose of 100 mg/kg, two-way ANOVA revealed a significant effect of ST 198 (F(1,48) ¼ 6.54, P ¼ 0.01), a significant effect of nicotine dose (F(4,48) ¼ 2.59, P ¼ 0.048), and a significant interaction between ST 198 and the dose of nicotine (F(4,48) ¼ 3.04, P ¼ 0.03). Post hoc analysis revealed a significant increase of response rates in the group of rats receiving 30 mg/kg ST 198 in combination with 0.01 mg/kg nicotine.
These results indicate that the two D 3 ligands do not alter the discriminative-stimulus effects of nicotine across a large range of nicotine doses, but do tend to increase response rates of the rats when given in combination with nicotine.
Experiment 3: Assessment of Antidepressant Actions of BP 897 with a Forced Swimming Test Figure 5a shows the time spent attempting to escape from the water-filled cylinders during the 4 min test period following administration of imipramine at a dose of 32 mg/ kg or BP 897 at doses of 1 and 2 mg/kg or saline vehicle.
One-way ANOVA indicated a significant effect of treatment (F(3,35) ¼ 32.6, Po0.0001). Post hoc analysis indicated a significant effect of imipramine (Po0.0001), but no effect of BP 897 at 1 and 2 mg/kg (P40.99). Figure 5b shows the time spent attempting to escape from the water-filled cylinders during the 4 min test period by D 3 R-deficient mice and their wild-type littermates following administration of imipramine or saline vehicle. Two-way ANOVA analysis of results indicated no effect of genotype (F(1,44) ¼ 0.05, P ¼ 0.82), a significant effect of imipramine (F(1,44) ¼ 10.88, Po0.002), and no interaction between genotype and imipramine treatment (F(1,44) ¼ 0.01, P ¼ 0.91). Post hoc analysis indicated no basal differences in escape behavior between D 3 R-deficient mice and their wild-type littermates (P ¼ 0.94) and a significant effect of imipramine in both D3R
þ / þ and D3R À/À mice (P ¼ 0.02 and P ¼ 0.03, respectively).
DISCUSSION
In the CPP paradigm, animals are tested in a drug-free state to determine whether they prefer an environment in which they previously received nicotine as compared to an environment in which they previously received saline (Le Foll and Goldberg, 2004a) . On the test day, the approach and association of the animals with the drug-paired side may be considered a measure of drug-seeking behavior. In agreement with our previous studies, a dose of 0.1 mg/kg nicotine induced significant CPP using a bias procedure, as compared to saline-conditioned animals (Le Foll and Goldberg, 2004a, b) . Two D 3 selective ligands, BP 897 and ST 198, dose-dependently blocked the expression of nicotine-induced CPPs, in agreement with the proposed role of D 3 Rs in reactivity to drug-associated cues. In parallel drug-discrimination studies, doses of BP 897 and ST 198, which effectively blocked the expression of nicotineinduced CPP, did not produce nicotine-like discriminative-stimulus effects when substituted for the training dose of nicotine, and did not significantly alter either the doseresponse curve for nicotine discrimination or the ED 50 values for nicotine discrimination. These findings suggest that BP 897 and ST 198 can act selectively to reduce the motivational effects of nicotine-associated stimuli.
Since pramipexole, a D 2 R/D 3 R agonist, is an effective treatment for depression in humans (Lattanzi et al, 2002; Ostow, 2002) and the antidepressants bupropion and nortriptyline have been used as aids for smoking cessation, as is proposed for BP 897 (Le Foll et al, 2003a) , we used a forced swimming test to assess the potential anti-depressant-like effects of BP 897 that may have contributed to its blockade of expression of nicotine-induced CPP. This test is sensitive to the effects of bupropion (Cooper et al, 1980) and other antidepressant drugs (Porsolt et al, 1978) . In contrast to the antidepressant, imipramine, which effectively increased performance (escape behavior) in the forced swimming test, doses of BP 897 as high as 2 mg/kg had no effect on performance in the forced swimming test. This is in agreement with the lack of efficacy of various dopaminergic ligands in this test (Renard et al, 2001) . D 3 R invalidation also had no effect on escape behavior in the forced swimming test and did not prevent the effects of It is unlikely that blockade of the expression of nicotineinduced CPP was due to a nonspecific disruptant effect of these D 3 R ligands on behavior, since, at these doses, BP 897 and ST 198 did not decrease locomotor activity in the CPP apparatus during test sessions and did not disrupt foodmaintained behavior under the drug-discrimination procedure. It is also unlikely that blockade of the expression of nicotine-induced CPP by BP 897 and ST 198 in the present experiments was due to direct effects on the memory of drug-associated stimuli, since BP 897 has no effect on habituation to neutral cues in an open field environment (Le Foll et al, 2002) . However, habituation may involve different memory processes than those needed for CPP. It is worth noting that BP 897 has no effect in the passive avoidance test, which measures reactivity to aversive stimuli and is also used as an animal model for anxiolytic effects of drugs (Le Foll et al, 2002) . This procedure involves association of a context with an unconditioned stimulus, which is more similar to the learning involved in CPP. Nevertheless, the 1 mg/kg dose of BP 897 did increase time spent in the nonpreferred side of the apparatus, an effect that may reflect anxiolytic properties of this ligand (Rogoz et al, 2003) . Finally, it is unlikely that a shift in the basal preference for one side of the apparatus during repeated conditioning sessions contributed to the present results with nicotine-induced CPP, since no shift was observed in saline-treated control rats. It is also unlikely that this effect is mediated through aversive properties of BP 897, since these later properties have been inconsistently found following repeated pairing of BP897 effects with a particular environment (Duarte et al, 2003; Gyertyan and Gal, 2003; Francès et al, 2004b) and in the present study BP 897 was only administered acutely during the test session.
Under some conditions, D 2 receptor blockade appears to disrupt conditioned associations between environmental stimuli and the interoceptive effects of psychoactive drugs. For example, raclopride, a preferential antagonist at D 2 R/ D 3 Rs (Sokoloff et al, 1990; Levant, 1997) , can block drugseeking behavior induced by the reintroduction of cocaineassociated stimuli (Weissenborn et al, 1996) . Such a D 2 receptor-mediated effect is, however, unlikely in the present experiments. First, BP 897 and ST 198 have a high affinity for the D 3 R (K i ¼ 0.92 and 12 nM for BP 897 and ST 198, respectively) and relatively high D 2 /D 3 selectivity (70 and 65 times lower affinity at the D 2 receptor for BP 897 and ST 198, respectively) . Although these ligands are able to occupy D 2 receptors in vivo, they do so only at much higher doses than those which blocked the expression of nicotineinduced CPP in the present experiments, as shown by other in vivo experiments. For instance, in D 3 R-deficient mice, cfos-activating effects of a 1 mg/kg dose of BP 897 were noted in wild-type mice, but not in D 3 knockout mice (Pilla et al, 1999) . The D 3 R selectivity of the does of BP 897 and by ST 198 used in the present study was also demonstrated by showing that the effects of these agents are abolished in D 3 R-deficient mice, but not in wild-type controls, using a behavioral model based on dizocilpine-induced locomotion, which allows the direct assessment of D 3 R blockade in vivo (Bezard et al, 2003; Leriche et al, 2003) . On the contrary, D 2 receptor occupancy is achieved by BP 897 at an ED 50 of B15 mg kg À1 and cataleptic effects of BP 897 appear with an ED 50 of B12 mg kg
À1
, and no effects could be detected at 1 mg/kg and lower on these paradigms, whereas these doses are active in blocking nicotine-induced CPP in our experiment. This is also illustrated by the finding that high doses of BP 897 were needed to decrease responding for food in the drug-discrimination paradigm (10 mg/kg), an effect typical of agents blocking D 2 receptors (Desai et al, 2003) , but 10-30-fold lower doses of BP 897 or ST 198 were effective in blocking the expression of nicotine-induced CPP. This is consistent with the absence of any significant motor effects induced by administration of BP 897 or ST 198 in the present CPP experiments or in previous published studies (Pilla et al, 1999; Le Foll et al, 2002 , 2003a .
The mechanism underlying the present effects of BP 897 and ST 198 on nicotine-induced CPP remains to be determined. BP 897 is a D 3 partial agonist (Pilla et al, 1999) . As a partial agonist, BP 897 may act as an antagonist in a situation of high dopamine transmission, a feature associated with presentation of drug-associated stimuli (Di Ciano et al, 1998a, b; Weiss et al, 2000) . Since, BP 897 and ST 198 had the same effect on nicotine-induced CPP, one hypothesis is that BP 897 acts like an antagonist in vivo in this paradigm. Another highly selective D 3 R antagonist, SB-277011-A, produces effects similar to BP 897, including disruption of nicotine-triggered relapse to nicotine-seeking behavior (Andreoli et al, 2003) , inhibition of cocaine (Le Foll et al, 2002) and nicotine conditioning (Le Foll et al, 2003a) , and reduction of cue-induced cocaine-seeking behavior (Pilla et al, 1999; Di Ciano et al, 2003) . Therefore, a blockade of dopamine transmission is likely to be involved. Since the D 3 Rs are overexpressed in the brain of cocaine- (Le Foll et al, 2002) and nicotine-treated (Le Foll et al, 2003a, b) animals, this antagonistic activity at D 3 Rs may serve to normalize dopamine transmission (Le Foll et al, 2003a) . This blockade of the dopamine transmission may also explain the ability of SB-277011-A to block nicotine-triggered relapse to nicotine-seeking behavior, since elevation in dopamine levels in the nucleus accumbens has been implicated in the initiation of drug-seeking behavior (Phillips et al, 2003) . Another possibility is that BP 897 reduces dopamine transmission through D 3 autoreceptors Le Foll et al, 2004) in the ventral tegmental area (Le Foll et al, 2002) . It also seems likely that other brain structures, such as the amygdala (Le Foll et al, 2002) and the somatosensory cortex (Le Foll et al, 2002; Francès et al, 2004a) , are involved.
In conclusion, the present findings show that administration of BP 897 and ST 198 is able to block the expression of nicotine-induced CPPs. These D 3 R ligands had no significant effects on the discriminative-stimulus effects of nicotine, indicating that their effects would be selective for those rewarding or reinforcing effects of nicotine that contribute to the maintenance of tobacco-smoking behavior, without affecting the ability to discriminate nicotine's other effects. Involvement of antidepressant actions in the present effects of BP 897 and ST 198 on CPP is unlikely, since we found no effect of D 3 R blockade or genetic depletion of D 3 Rs in the forced swimming test, suggesting that the mechanism by which D 3 R ligands reduce the motivational effects of nicotine are distinct from those of bupropion. The present findings support and extend previous findings that D 3 R partial agonists and antagonists attenuate conditioned responses to various types of drugassociated stimuli and lend support to the proposed use of these compounds as aids in smoking cessation treatment.
